Power the industry. Fast.
We collaborate with leading biopharmaceutical companies to extend the reach of our technology and accelerate the next generation of RNA medicines.
Through partnerships, we combine SymphoRNA’s delivery and therapeutic engine with partner targets — enabling any nucleic acid to reach any cell or tissue, while expanding therapeutic reach through multi-target modulation.
Our goal is simple: to expand the impact of multi-target RNA medicines — tackling more diseases, having greater impact, and doing it faster than ever before.